← Back to Analyst Consensus 
ASMB Buy
ASSEMBLY BIOSCIENCES, INC.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 1, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Sep 1, 2026 | UBS | initiate | — → Buy | — | 54% |
| Aug 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 28, 2026 | Guggenheim | reiterate | Buy → Buy | — | 52% |
| May 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 6, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 26, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Dec 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Nov 20, 2025 | Mizuho | maintain | Outperform → Outperform | $40 | 52% |
| Oct 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Sep 24, 2025 | JMP Securities | initiate | — → Market Outperform | $38 | 53% |
| Sep 8, 2025 | Guggenheim | maintain | Buy → Buy | $39 | 52% |
| Mar 25, 2025 | Guggenheim | initiate | — → Buy | $31 | 52% |
| Mar 24, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Dec 27, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Jun 20, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Jun 13, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Apr 1, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
Price Target Trend
Jun 14, 2026 Latest: $52 Oct 24, 2026
EPS Estimates
0y $-0.12
Lo: $-2.86 Hi: $2.28
4 analysts ▲2
+1y $-2.57
Lo: $-4.83 Hi: $0.05
4 analysts ▲1
0q $-0.49
Lo: $-1.12 Hi: $-0.16
4 analysts ▲2
+1q $0.85
Lo: $-1.17 Hi: $3.19
4 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days